Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...
Drug design and development is expensive, often insufficient, and laced with the tendency for failure. Traditionally, it’s a hit-and-miss process that can stretch over a decade and consume around $2.3 ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Garry Pairaudeau, Chief Technology Officer at Exscientia*, about pharmatech, AI, and more. My name is Garry Pairaudeau, ...
In recent years, target-based drug discovery has undergone a renaissance thanks to polypharmacology. In contrast to the conventional lock-and-key or one target-one drug model of drug design, ...
Of the thousands of diseases that affect humans, treatments exist for only a handful. This lack of available therapeutics and efficiency in drug discovery and development processes is poised for ...
Conventional drug delivery is known for being both a lengthy and expensive process, with pre-clinical testing taking between three to six years and costing between hundreds of millions of dollars to ...
Explore the potential of light-driven chemistry to revolutionize drug design, making it safer and more efficient.
Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...